Denis M. Grant

7.0k total citations
90 papers, 5.3k citations indexed

About

Denis M. Grant is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Denis M. Grant has authored 90 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 22 papers in Cancer Research and 18 papers in Pharmacology. Recurrent topics in Denis M. Grant's work include Carcinogens and Genotoxicity Assessment (19 papers), Polyamine Metabolism and Applications (17 papers) and Pharmacogenetics and Drug Metabolism (16 papers). Denis M. Grant is often cited by papers focused on Carcinogens and Genotoxicity Assessment (19 papers), Polyamine Metabolism and Applications (17 papers) and Pharmacogenetics and Drug Metabolism (16 papers). Denis M. Grant collaborates with scholars based in Canada, United States and Norway. Denis M. Grant's co-authors include Urs Meyer, Martin Blum, Markus H. Heim, Andrea Gaedigk, Geoffrey H. GOODFELLOW, W. Kalow, Bing Tang, David W. Hein, Kim S. Sugamori and J M Dupret and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Denis M. Grant

88 papers receiving 5.2k citations

Peers

Countries citing papers authored by Denis M. Grant

Since Specialization

Citations

This map shows the geographic impact of Denis M. Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis M. Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis M. Grant more than expected).

Fields of papers citing papers by Denis M. Grant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis M. Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis M. Grant. The network helps show where Denis M. Grant may publish in the future.

Co-authorship network of co-authors of Denis M. Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Denis M. Grant. A scholar is included among the top collaborators of Denis M. Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis M. Grant. Denis M. Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The mast cell-T lymphocyte axis impacts cancer: Friend or foe? 2024 ·Cancer Letters ·Vinicius Kannen, Denis M. Grant, Jason Matthews	5
2	Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity 2023 ·Cancers ·(unknown), (unknown), Vinicius Kannen, (unknown), (unknown), Giulia Grimaldi, Akinori Takaoka, Denis M. Grant, Jason Matthews	18
3	Reduced Colonic Mucosal Injury in 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Poly ADP-Ribose Polymerase (TIPARP/PARP7)-Deficient Mice 2022 ·International Journal of Molecular Sciences ·David Hutin, (unknown), Peng Shao, Kim S. Sugamori, Denis M. Grant, Jason Matthews	10
4	The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis 2020 ·Toxicology ·(unknown), Kim S. Sugamori, (unknown), Denis M. Grant	4
5	Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen 2019 ·Pharmacology & Therapeutics ·Shuang Wang, (unknown), Kim S. Sugamori, Denis M. Grant	55
6	Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome 2018 ·Toxicological Sciences ·David Hutin, Laura Tamblyn, Alvin Gomez, Giulia Grimaldi, (unknown), Tiffany Cho, Shaimaa Ahmed, (unknown), Chakravarthi Kanduri, Denis M. Grant, Jason Matthews	19
7	Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes 2015 ·Diabetes Technology & Therapeutics ·Karen Eny, Trevor J. Orchard, Rachel G. Miller, John Maynard, Denis M. Grant, Tina Costacou, Patricia A. Cleary, Barbara H. Braffett, Andrew D. Paterson	16
8	Relative Contributions of CYP1A2 and CYP2E1 to the Bioactivation and Clearance of 4-Aminobiphenyl in Adult Mice 2015 ·Drug Metabolism and Disposition ·Shuang Wang, (unknown), (unknown), Kim S. Sugamori, Denis M. Grant	9
9	Effect of Arylamine Acetyltransferase Nat3 Gene Knockout on N-Acetylation in the Mouse 2007 ·Drug Metabolism and Disposition ·Kim S. Sugamori, (unknown), Shan S. Wong, Andrea Gaedigk, Valen Zhuoyou Yu, H Abramovici, Richard Rozmahel, Denis M. Grant	17
10	Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects 2001 ·Pharmacogenetics ·S. A. Vaziri, Nicola Hughes, Heather Sampson, Gerarda Darlington, Michael A.S. Jewett, Denis M. Grant	33
11	Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop 2001 ·Biochemical Journal ·Fernando Rodrigues‐Lima, Claudine Deloménie, Geoffrey H. GOODFELLOW, Denis M. Grant, Jean‐Marie Dupret	50
12	A SNPshot: pharmacogenetics and the future of drug therapy 2000 ·Trends in biotechnology ·(unknown), Michael T. Boyce-Jacino, Denis M. Grant	41
13	Pharmacogenetics of the Human Arylamine N-Acetyltransferases 2000 ·Pharmacology ·Denis M. Grant, Geoffrey H. GOODFELLOW, Kim S. Sugamori, (unknown)	43
14	Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe 1998 ·Pharmacogenetics ·Nicola Hughes, Susan A. Janezic, Karina L. McQueen, Michael A.S. Jewett, Trisha Castranio, Douglas A. Bell, Denis M. Grant	108
15	The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies 1997 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Kelly Windmill, Ross A. McKinnon, Xiaoyi Zhu, Andrea Gaedigk, Denis M. Grant, Michael E. McManus	114
16	Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations 1996 ·Pharmacogenetics ·Uwe Fuhr, Karl Ludwig Rost, R. Engelhardt, Michael Sachs, Dieter Liermann, Claire Belloc, Philippe Beaune, Susan A. Janezic, Denis M. Grant, Urs Meyer, A. H. Staib	98
17	Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism 1993 ·Biochemical Pharmacology ·Alastair E. Cribb, Hidefumi Nakamura, Denis M. Grant, Margaret A. Miller, Stephen P. Spielberg	58
18	Polymorphisms of N-acetyltransferase genes 1992 ·Xenobiotica ·Denis M. Grant, Martin Blum, Urs Meyer	19
19	Genetic Polymorphisms of Drug-Metabolizing Enzymes: Molecular Mechanisms 1989 ·PubMed ·Urs Meyer, Ulrich M. Zanger, Radek C. Skoda, Denis M. Grant	2
20	Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation 1989 ·Nucleic Acids Research ·Denis M. Grant, Martin Blum, (unknown), Urs Meyer	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact